title: Dramatic increase of tacrolimus plasma concentration during topical treatment for oral graft-versus-host disease.
authors.forename: Davide
authors.initials: D
authors.lastname: Conrotto
authors.forename: Marco
authors.initials: M
authors.lastname: Carrozzo
authors.forename: Ape Valeria
authors.initials: AV
authors.lastname: Ubertalli
authors.forename: Sergio
authors.initials: S
authors.lastname: Gandolfo
authors.forename: Luisa
authors.initials: L
authors.lastname: Giaccone
authors.forename: Mario
authors.initials: M
authors.lastname: Boccadoro
authors.forename: Benedetto
authors.initials: B
authors.lastname: Bruno
authors.forename: Bruno
authors.initials: B
authors.lastname: Benedetto
mesh_terms: D000208:Acute Disease; D000287:Administration, Topical; D005260:Female; D006086:Graft vs Host Disease / Q000188:drug therapy*; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects* / Q000097:blood*; D008875:Middle Aged; D009061:Mouth Mucosa / Q000187:drug effects* / Q000473:pathology; D009101:Multiple Myeloma / Q000628:therapy; D016559:Tacrolimus / Q000009:adverse effects* / Q000097:blood*; D013997:Time Factors; D019172:Transplantation Conditioning
chemical_list: D007166:Immunosuppressive Agents; D016559:Tacrolimus